Secreting products from skin by adeno-associated virus (AAV) gene transfer

Abstract

The present invention utilizes AAV as a vector to transfect epithelial cells with an AAV/heterologous gene containing/Neo vector, to form a heterologous protein secreting culture of epithelial cells. This culture is useful for preparing recombinant skin using the organotypic epithelial raft culture system. The sheets of epithelial cells is composed of a stratified sqaumous epithelium composed of a lower layer of immature basal cells and an upper layer of mature keratinized epithelium. The rAAV virus stock prepared without wild type AAV is useful in expressing heterologous protein, however, the maximum production of the heterologous protein was achieved; when the rAAV virus stock contained wild type AAV. This invention discloses that AAV is appropriate for genetically altering skin to secrete new proteins to treat diseases and skin disorders or conditions.

What is claimed is:  
     
         1 . A method of preparing epithelial cells that express at least one heterologous protein comprising: 
 (a) transfecting at least one epithelial cell with an AAV vector comprising at least one gene encoding a heterologous protein operably linked to a promoter functional in said epithelial cell; and    (b) culturing said transfected epitheilial cell that expresses said heterologous protein.    
     
     
         2 . The method of  claim 1 , wherein said epithelial cell is a keratinocyte.  
     
     
         3 . The method of  claim 2 , wherein said keratinocyte is a primary keratinocyte.  
     
     
         4 . The method of  claim 1 , wherein said culturing results in the production of sheets of epithelial cells, wherein said sheet comprises a stratified squamous epithelium.  
     
     
         5 . The method of  claim 4 , wherein said culturing utilizes the organotypic epithelial raft culture system.  
     
     
         6 . The method of  claim 1 , wherein said promoter is an AAV specific promoter or a skin specific promoter.  
     
     
         7 . A method of producing a heterologous protein in epithelial cells comprising: 
 (a) transfecting at least one epithelial cell with an AAV vector comprising at least one gene encoding a heterologous protein operably linked to a promoter functional in said epithelial cell;    (b) culturing said transfected epitheilial cell that expresses said heterologous protein, and    (c) expressing said heterologous protein in said epithelial cells.    
     
     
         8 . The method of  claim 7 , wherein said heterologous protein is secreted into culture media in which said epithelial cells are cultured.  
     
     
         9 . The method of  claim 7 , wherein said epithelial cell is a keratinocyte.  
     
     
         10 . The method of  claim 9 , wherein said keratinocyte is a primary keratinocyte.  
     
     
         11 . The method of  claim 7 , wherein said culturing results in the production of sheets of epithelial cells comprising a stratified squamous epithelium.  
     
     
         12 . The method of  claim 11 , wherein said culturing utilizes the organotypic epithelial raft culture system.  
     
     
         13 . The method of  claim 7 , wherein said promoter is an AAV specific promoter or a skin specific promoter.  
     
     
         14 . A method of producing a sheet of epithelial cells that express a heterologous protein comprising: 
 (a) transfecting at least one epithelial cell with an AAV vector comprising at least one gene encoding a heterologous protein operably linked to a promoter functional in said epithelial cell;    (b) culturing said transfected epitheilial cell that expresses said heterologous protein, whereby a sheet of epithelial cells is formed on a surface within a culture vessel, and wherein said sheet comprises a stratified squamous epithelium; and    (c) removing said sheet of epithelial cells from said surface.    
     
     
         15 . The method of  claim 14 , wherein said epithelial cell is a keratinocyte.  
     
     
         16 . The method of  claim 15 , wherein said keratinocyte is a primary keratinocyte.  
     
     
         17 . The method of  claim 14 , wherein said promoter is an AAV specific promoter or a skin specific promoter.  
     
     
         18 . The method of  claim 14 , wherein said culturing utilizes the organotypic epithelial raft culture system.  
     
     
         19 . A transfected epithelial cell comprising a recombinant AAV (rAAV) comprising at least one gene encoding a heterologous protein operably linked to a promoter functional in said epithelial cell.  
     
     
         20 . A sheet of transfected epithelial cells of  claim 19 .  
     
     
         21 . The sheet of transfected epithelial cells of  claim 20 , wherein said sheet comprises a stratified squamous epithelium.  
     
     
         22 . The sheet of  claim 21 , prepared according to a culturing method comprising the organotypic epithelial raft culture system.  
     
     
         23 . A method of treating a subject in need of a treatment by a heterologous protein comprising: 
 (a) contacting the skin of a subject with a sheet of transfected epithelial cells of  claim 21;  and    (b) allowing said sheet of transfected epithelial cells to express said heterologous protein.    
     
     
         24 . The method of  claim 23 , wherein said sheet comprises a stratified squamous epithelium.  
     
     
         25 . The method of  claim 23 , wherein said expressed heterologous protein is secreted into the skin of said subject.  
     
     
         26 . The method of  claim 23 , wherein said epithelial cell is a keratinocyte.  
     
     
         27 . The method of  claim 26 , wherein said keratinocyte is a primary keratinocyte.  
     
     
         28 . The method of  claim 23 , wherein said promoter is an AAV specific promoter or a skin specific promoter.